cd8+ t cells
Cell therapyexperimental
Clinical trial activity
5 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2015 (NCT02027935)
Timeline
Indications
Studied for
- Biomarkers · Phase 1
- Carcinoma, Hepatocellular · Phase 1/Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 1/Phase 2
- Carcinoma, Renal Cell · Phase 1/Phase 2
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive · Phase 2
- Leukemia, Myeloid, Acute · Phase 2
- Liver Neoplasms · Phase 1
- Melanoma · Phase 2
- Myelodysplastic Syndromes · Phase 2
- Ovarian Neoplasms · Phase 1
- Pancreatic Neoplasms · Phase 1/Phase 2
- Precursor Cell Lymphoblastic Leukemia-Lymphoma · Phase 2
- Small Cell Lung Carcinoma · Phase 1/Phase 2
- Stomach Neoplasms · Phase 1/Phase 2
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cd 8+ t cells
- cd8+ t cells
- cd8+t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04151706 | Phase 2 | Nov 30, 2019 | Stanford University |
| NCT03318900 | Phase 1 | Jul 16, 2018 | immatics Biotechnologies GmbH, Markel/Friedman Accelerator Fund, Pfizer, University of Texas at Houston |
| NCT03068624 | Phase 1 | Jun 1, 2017 | University of Texas at Houston |
| NCT03093688 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2017 | Fudan University |
| NCT02027935 | Phase 2 | Jan 1, 2015 | American Association for Cancer Research, State of Texas, University of Texas at Houston |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Texas at Houston | Academic/Hospital | 3 | 3 | 2 | 2015 |
| American Association for Cancer Research | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Fudan University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| immatics Biotechnologies GmbH | For profit | 1 | 0 | 1 | 2018 |
| Markel/Friedman Accelerator Fund | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Pfizer | For profit | 1 | 0 | 1 | 2018 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| State of Texas | Government | 1 | 0 | 1 | 2015 |
8 organizations
Page 1 / 1